Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
The nuclei of brain stem cells in some Parkinson’s patients become misshapen with age. The discovery opens up new ways to target the disease.
Scientists corrected a genetic error in stem cells from patients with liver disease, and implanted those cells in the livers of mice.
A technology used to develop new medical treatments might one day revive endangered or extinct species.
Reprogrammed stem cells from schizophrenia patients could help researchers study the disease more closely, and test drugs to fight it.
The findings cast doubt on a promising alternative to the use of embryonic stem cells in medicine.
Some scientists are reluctant to enter the field, and some consider leaving it altogether, because of the uncertainty of government regulations.
Engineered stem cells carry markers of their former identities–a trait that could hinder research into diseases.
Scientists are creating collections of reprogrammed stem cells to use for transplants and drug testing.
Cells from people with premature aging disease get “younger” with the help of stem cell technology.
Photoreceptors created from induced pluripotent stem cells.